|
US3076817A
(en)
*
|
|
1963-02-05 |
|
New j-amino-thiophene-z |
|
DE1055007B
(de)
|
1957-08-29 |
1959-04-16 |
Dr Hans Fiesselmann |
Verfahren zur Herstellung von 3-Aminothiophen-2-carbonsaeureestern und den entsprechenden freien Carbonsaeuren
|
|
US3470151A
(en)
*
|
1966-05-17 |
1969-09-30 |
Beecham Group Ltd |
Furyl- and thienyl-penicillins and salts thereof
|
|
AU518216B2
(en)
*
|
1977-09-06 |
1981-09-17 |
Hafslund Nycomed Pharma Aktiengesellschaft |
Thienothiazine derivatives
|
|
US4244205A
(en)
|
1978-04-25 |
1981-01-13 |
Wean United Inc. |
Apparatus for aligning extrusion producing members of a press
|
|
DD146952A1
(de)
|
1979-11-09 |
1981-03-11 |
Karl Gewald |
Verfahren zur herstellung von substituierten 3-amino-4-cyan-5-phenylthiophenen
|
|
JPS57116077A
(en)
|
1981-01-12 |
1982-07-19 |
Kanebo Ltd |
Thieno(3,2-b)pyridinecarboxylic acid derivative
|
|
GB8515207D0
(en)
*
|
1985-06-15 |
1985-07-17 |
Boots Co Plc |
Therapeutic agents
|
|
GB8627698D0
(en)
|
1986-11-20 |
1986-12-17 |
Boots Co Plc |
Therapeutic agents
|
|
DD263055A1
(de)
|
1987-07-28 |
1988-12-21 |
Univ Dresden Tech |
Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene
|
|
DE4023048A1
(de)
*
|
1990-07-20 |
1992-01-23 |
Basf Ag |
Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
|
JP2574085B2
(ja)
|
1991-10-28 |
1997-01-22 |
株式会社トクヤマ |
３−アミノ−２−チオフェンカルボン酸誘導体の製造方法
|
|
FR2689129B1
(fr)
|
1992-03-27 |
1995-05-12 |
Atochem Elf Sa |
Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
|
|
JPH0625221A
(ja)
|
1992-07-10 |
1994-02-01 |
Tokuyama Soda Co Ltd |
３−アミノ−２−チオフェンカルボン酸誘導体の製造方法
|
|
JPH0748360A
(ja)
|
1993-05-31 |
1995-02-21 |
Yoshitomi Pharmaceut Ind Ltd |
ビフェニルテトラゾール誘導体
|
|
EP0658559A1
(de)
*
|
1993-12-14 |
1995-06-21 |
Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. |
Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
|
|
DE19522603A1
(de)
*
|
1995-06-19 |
1997-01-09 |
Siemens Ag |
Schutzeinrichtung gegen Überlastung der Schaltkontakte eines Schaltgerätes
|
|
KR100423590B1
(ko)
*
|
1995-08-02 |
2004-09-10 |
호따. 우리아치에씨아. 에세. 아. |
항진균활성을갖는신규피리미돈유도체
|
|
BR9606546A
(pt)
*
|
1995-08-02 |
1998-07-14 |
Uriach & Cia Sa J |
Novas carboxamidas com atividade fungicida
|
|
AP1019A
(en)
|
1996-10-18 |
2001-10-16 |
Vertex Pharma |
Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
|
|
JP4000608B2
(ja)
*
|
1996-11-07 |
2007-10-31 |
トヨタ自動車株式会社 |
水素製造充填装置および電気自動車
|
|
TW523506B
(en)
*
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
US6117911A
(en)
*
|
1997-04-11 |
2000-09-12 |
Neorx Corporation |
Compounds and therapies for the prevention of vascular and non-vascular pathologies
|
|
AP9901643A0
(en)
*
|
1997-04-28 |
1999-10-02 |
Texas Biotechnology Corp |
Sulfonamides for treatment of endothelin-mediated disorders.
|
|
US5783705A
(en)
*
|
1997-04-28 |
1998-07-21 |
Texas Biotechnology Corporation |
Process of preparing alkali metal salys of hydrophobic sulfonamides
|
|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
ES2241157T3
(es)
|
1997-08-11 |
2005-10-16 |
Boehringer Ingelheim (Canada) Ltd. |
Peptidos inhibidores de la hepatitis c.
|
|
EP1012180B1
(en)
|
1997-08-11 |
2004-12-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
|
DE69816102D1
(de)
*
|
1997-09-02 |
2003-08-07 |
Mitsubishi Pharma Corp |
Kondensierte thiophenderivate und ihre medizinische anwendung
|
|
US6140351A
(en)
*
|
1997-12-19 |
2000-10-31 |
Berlex Laboratories, Inc. |
Ortho-anthranilamide derivatives as anti-coagulants
|
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
AU2003204708B2
(en)
|
1997-12-22 |
2006-05-25 |
Bayer Healthcare Llc |
Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
|
|
US6291514B1
(en)
*
|
1998-02-09 |
2001-09-18 |
3-Dimensional Pharmaceuticals, Inc. |
Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
|
|
US20050119332A1
(en)
*
|
1998-03-12 |
2005-06-02 |
Lone Jeppesen |
Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
|
|
US6262044B1
(en)
*
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
|
US6214879B1
(en)
*
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
|
US6689754B1
(en)
*
|
1998-04-10 |
2004-02-10 |
G. D. Searle & Co. |
Heterocyclic glycyl β-alanine derivatives
|
|
ATE228119T1
(de)
*
|
1998-04-15 |
2002-12-15 |
Pfizer Prod Inc |
Heterocyclische carboxamide
|
|
EP0960882A1
(en)
*
|
1998-05-19 |
1999-12-01 |
Hoechst Marion Roussel Deutschland GmbH |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
|
|
US6858223B2
(en)
*
|
1998-06-23 |
2005-02-22 |
Altana Pharma Ag |
Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
|
|
AU4385399A
(en)
*
|
1998-06-29 |
2000-01-17 |
Biochem Pharma Inc. |
Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
|
|
AU756627B2
(en)
|
1998-07-27 |
2003-01-16 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Diketoacid-derivatives as inhibitors of polymerases
|
|
AR022061A1
(es)
|
1998-08-10 |
2002-09-04 |
Boehringer Ingelheim Ca Ltd |
Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
|
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
US7101878B1
(en)
*
|
1998-08-20 |
2006-09-05 |
Agouron Pharmaceuticals, Inc. |
Non-peptide GNRH agents, methods and intermediates for their preparation
|
|
DE19903398A1
(de)
|
1999-01-29 |
2000-08-10 |
Hassan Jomaa |
Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen
|
|
EP1152759A2
(en)
*
|
1999-02-09 |
2001-11-14 |
3-Dimensional Pharmaceuticals, Inc. |
METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
|
|
NZ528846A
(en)
*
|
1999-03-12 |
2005-05-27 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
|
WO2000055152A1
(en)
*
|
1999-03-12 |
2000-09-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
JP2001010957A
(ja)
|
1999-04-28 |
2001-01-16 |
Sankyo Co Ltd |
肝障害の予防または抑制剤
|
|
DE19920247A1
(de)
|
1999-05-03 |
2000-11-16 |
Hassan Jomaa |
Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung
|
|
HN2000000051A
(es)
*
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
|
US6867217B1
(en)
*
|
1999-05-19 |
2005-03-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
|
|
GB9929552D0
(en)
*
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
CA2385972A1
(en)
|
1999-10-01 |
2001-04-12 |
Haruhisa Ogita |
Novel diarylamide derivatives and use thereof as medicines
|
|
KR20020058046A
(ko)
*
|
1999-11-29 |
2002-07-12 |
한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 |
살충성 ｎ-헤테로아릴 알파-알콕시미노-카르복사미드
|
|
EP1162196A4
(en)
|
1999-12-27 |
2003-04-16 |
Japan Tobacco Inc |
COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
|
|
DE10002424A1
(de)
*
|
2000-01-20 |
2001-07-26 |
Siemens Ag |
Di(het)arylaminothiophen-Derivate
|
|
GB0003154D0
(en)
*
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
MY138097A
(en)
*
|
2000-03-22 |
2009-04-30 |
Du Pont |
Insecticidal anthranilamides
|
|
US20040034041A1
(en)
|
2000-05-10 |
2004-02-19 |
Dashyant Dhanak |
Novel anti-infectives
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
JP2001354658A
(ja)
|
2000-06-15 |
2001-12-25 |
Taisho Pharmaceut Co Ltd |
ヒドロキシホルムアミジン化合物及びその塩並びにそれらを含む医薬
|
|
US6414013B1
(en)
*
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
ES2271109T3
(es)
*
|
2000-11-08 |
2007-04-16 |
Syngenta Participations Ag |
Pirrocarboxamidas y pirrolcarbotioamidas y sus usos agroquimicos.
|
|
ES2263687T3
(es)
|
2000-11-20 |
2006-12-16 |
Bristol-Myers Squibb Company |
Inhibidores tripeptidicos de la hepatitis c.
|
|
US7015223B1
(en)
*
|
2000-11-20 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
|
|
US6892279B2
(en)
*
|
2000-11-30 |
2005-05-10 |
Mosaid Technologies Incorporated |
Method and apparatus for accelerating retrieval of data from a memory system with cache by reducing latency
|
|
DE10061876A1
(de)
*
|
2000-12-12 |
2002-06-20 |
Aventis Pharma Gmbh |
Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
WO2002057425A2
(en)
|
2001-01-22 |
2002-07-25 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
DE60239097D1
(de)
|
2001-03-02 |
2011-03-17 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
US20040102324A1
(en)
*
|
2002-02-28 |
2004-05-27 |
Annis Gary David |
Heterocyclic diamide invertebrate pest control agents
|
|
AU2002252183A1
(en)
|
2001-03-06 |
2002-09-19 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
US6734207B2
(en)
*
|
2001-04-20 |
2004-05-11 |
Parker Hughes Institute |
Cytotoxic compounds
|
|
EP1256628A3
(en)
|
2001-05-10 |
2003-03-19 |
Agouron Pharmaceuticals, Inc. |
Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
|
|
US6713638B2
(en)
*
|
2001-05-18 |
2004-03-30 |
Joel M. Linden |
2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
|
|
AR036081A1
(es)
|
2001-06-07 |
2004-08-11 |
Smithkline Beecham Corp |
Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
|
|
US6887877B2
(en)
*
|
2001-06-11 |
2005-05-03 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
CN101624391A
(zh)
*
|
2001-06-11 |
2010-01-13 |
病毒化学医药公司 |
用作黄病毒感染抗病毒剂的噻吩衍生物
|
|
SE0102102D0
(sv)
*
|
2001-06-13 |
2001-06-13 |
Hoeganaes Ab |
High density stainless steel products and method for the preparation thereof
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
SE0102616D0
(sv)
*
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
SE0102617D0
(sv)
*
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
US6689854B2
(en)
|
2001-08-23 |
2004-02-10 |
3M Innovative Properties Company |
Water and oil repellent masonry treatments
|
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するＲｈｏキナーゼ阻害剤
|
|
US6924276B2
(en)
*
|
2001-09-10 |
2005-08-02 |
Warner-Lambert Company |
Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
|
|
WO2003026587A2
(en)
|
2001-09-26 |
2003-04-03 |
Bristol-Myers Squibb Company |
Compounds useful for treating hepatitus c virus
|
|
DE60229975D1
(de)
*
|
2001-10-04 |
2009-01-02 |
Smithkline Beecham Corp |
Nf-kb-inhibitoren
|
|
US7285557B2
(en)
*
|
2001-10-15 |
2007-10-23 |
Smithkline Beecham P.L.C. |
Pyrimidinones as melanin concentrating hormone receptor 1
|
|
US7220777B2
(en)
*
|
2001-10-15 |
2007-05-22 |
Smithkline Beecham P.L.C. |
Lactam derivatives as antagonists for human 11cby receptors
|
|
AU2002348414B2
(en)
|
2001-10-24 |
2009-10-01 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine protease, particularly hepatitis C virus NS3-NS4A protease, incorporating a fused ring system
|
|
TWI281916B
(en)
*
|
2001-10-25 |
2007-06-01 |
Lilly Co Eli |
Antitumor compounds and methods
|
|
WO2003055479A1
(en)
*
|
2001-12-21 |
2003-07-10 |
Consejo Superior De Investigaciones Cientificas |
Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3
|
|
US6835745B2
(en)
*
|
2002-01-15 |
2004-12-28 |
Wyeth |
Phenyl substituted thiophenes as estrogenic agents
|
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
AU2003223602B8
(en)
|
2002-04-11 |
2010-05-27 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis C virus NS3-NS4 protease
|
|
HRP20041220A2
(hr)
*
|
2002-05-28 |
2006-04-30 |
3-Dimensional Pharmaceuticals |
Novi tiofen amidini, njihovi pripravci i postupci liječenja komplementom posredovanih bolesti i stanja
|
|
CN1155679C
(zh)
|
2002-09-20 |
2004-06-30 |
华南理工大学 |
含低聚噻吩骨格的液晶化合物及其制备方法
|
|
US7179836B2
(en)
*
|
2002-09-20 |
2007-02-20 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
US7902203B2
(en)
*
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
|
US20050075331A1
(en)
*
|
2003-10-06 |
2005-04-07 |
Pratt John K. |
Anti-infective agents
|
|
US20040162285A1
(en)
*
|
2002-11-01 |
2004-08-19 |
Pratt John K. |
Anti-infective agents
|
|
US20040097492A1
(en)
*
|
2002-11-01 |
2004-05-20 |
Pratt John K |
Anti-infective agents
|
|
EP2361913A1
(en)
|
2002-11-01 |
2011-08-31 |
Abbott Laboratories |
Anti-infective agents
|
|
DE10253220A1
(de)
*
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
JP4926403B2
(ja)
*
|
2002-12-10 |
2012-05-09 |
ヴァイロケム ファーマ インコーポレイテッド |
フラビウイルス感染の処置もしくは予防のための化合物および方法
|
|
AU2003291886A1
(en)
|
2002-12-10 |
2004-06-30 |
Virochem Pharma Inc. |
Thiophenederivatives for the treatment of flavivirus infections
|
|
US7402608B2
(en)
|
2002-12-10 |
2008-07-22 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
US7098241B2
(en)
*
|
2002-12-16 |
2006-08-29 |
Hoffmann-La Roche Inc. |
Thiophene hydroxamic acid derivatives
|
|
US7196114B2
(en)
*
|
2003-02-17 |
2007-03-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
|
|
EP1636208B1
(en)
|
2003-04-11 |
2012-02-29 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
WO2004092161A1
(en)
|
2003-04-11 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
EP1646642A2
(en)
|
2003-07-18 |
2006-04-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
UY28500A1
(es)
|
2003-09-05 |
2005-04-29 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
|
|
WO2005028502A1
(en)
|
2003-09-18 |
2005-03-31 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
TW200512181A
(en)
*
|
2003-09-26 |
2005-04-01 |
Tanabe Seiyaku Co |
Amide-type carboxamide derivatives
|
|
DE10359791A1
(de)
*
|
2003-12-19 |
2005-07-21 |
Bayer Healthcare Ag |
Substituierte Thiophene
|
|
WO2005077969A2
(en)
|
2004-02-04 |
2005-08-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
JP2007530516A
(ja)
*
|
2004-03-26 |
2007-11-01 |
スミスクライン・ビーチャム・コーポレイション |
抗ウイルス剤として有用な４−カルボキシピラゾール誘導体
|
|
MXPA06010520A
(es)
*
|
2004-03-30 |
2007-03-26 |
Chiron Corp |
Derivados de tiofeno sustituidos como agentes anticancerosos.
|
|
EP1771169A1
(en)
|
2004-07-14 |
2007-04-11 |
PTC Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
RU2007116265A
(ru)
|
2004-10-01 |
2008-11-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Ингибирование протеазы ns3-ns4a вируса hcv
|
|
DE102004061746A1
(de)
*
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Alkinyl-substituierte Thiophene
|
|
DE102005028077A1
(de)
|
2004-12-22 |
2006-07-13 |
Aicuris Gmbh & Co. Kg |
Alkinyl-substituierte Thiophene
|
|
BRPI0610283A2
(pt)
|
2005-05-13 |
2010-10-19 |
Virochem Pharma Inc |
composto, uso do mesmo na preparação de um medicamento para o tratamento ou prevenção de uma infecção por vìrus de hepatite c, composição farmacêutica e combinação farmacêutica
|
|
US20100160255A1
(en)
*
|
2005-07-29 |
2010-06-24 |
Takeda Pharmaceutical Company Limited |
Spiro-cyclic compound
|